190 related articles for article (PubMed ID: 1863104)
1. Alteration of urinary carnitine profile induced by benzoate administration.
Sakuma T
Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
[TBL] [Abstract][Full Text] [Related]
2. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
[TBL] [Abstract][Full Text] [Related]
3. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
[TBL] [Abstract][Full Text] [Related]
4. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
Ratnakumari L; Qureshi IA; Butterworth RF
Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
[TBL] [Abstract][Full Text] [Related]
6. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal.
Feoli-Fonseca JC; Lambert M; Mitchell G; Melançon SB; Dallaire L; Millington DS; Qureshi IA
Biochem Mol Med; 1996 Feb; 57(1):31-6. PubMed ID: 8812724
[TBL] [Abstract][Full Text] [Related]
7. Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: significance of acetylcarnitine determination to estimate the proper carnitine dose.
Itoh T; Ito T; Ohba S; Sugiyama N; Mizuguchi K; Yamaguchi S; Kidouchi K
Tohoku J Exp Med; 1996 Jun; 179(2):101-9. PubMed ID: 8875766
[TBL] [Abstract][Full Text] [Related]
8. Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine.
Michalak A; Qureshi IA
Biomed Pharmacother; 1995; 49(7-8):350-7. PubMed ID: 8562862
[TBL] [Abstract][Full Text] [Related]
9. Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency.
Matsuda I; Ohtani Y; Ohyanagi K; Yamamoto S
Enzyme; 1987; 38(1-4):251-5. PubMed ID: 3440448
[TBL] [Abstract][Full Text] [Related]
10. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
Michalak A; Qureshi IA
Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
[TBL] [Abstract][Full Text] [Related]
12. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups.
Roe CR; Hoppel CL; Stacey TE; Chalmers RA; Tracey BM; Millington DS
Arch Dis Child; 1983 Nov; 58(11):916-20. PubMed ID: 6651329
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
[TBL] [Abstract][Full Text] [Related]
14. A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.
Mori T; Tsuchiyama A; Nagai K; Nagao M; Oyanagi K; Tsugawa S
Eur J Pediatr; 1990 Jan; 149(4):272-4. PubMed ID: 2303075
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
Chalmers RA; Roe CR; Stacey TE; Hoppel CL
Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
[TBL] [Abstract][Full Text] [Related]
16. Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation.
Duran M; Ketting D; Beckeringh TE; Leupold D; Wadman SK
J Inherit Metab Dis; 1986; 9(2):202-7. PubMed ID: 3091925
[TBL] [Abstract][Full Text] [Related]
17. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
[TBL] [Abstract][Full Text] [Related]
18. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans.
Kubota K; Ishizaki T
Eur J Clin Pharmacol; 1991; 41(4):363-8. PubMed ID: 1804654
[TBL] [Abstract][Full Text] [Related]
20. Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis.
Brusilow S; Tinker J; Batshaw ML
Science; 1980 Feb; 207(4431):659-61. PubMed ID: 6243418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
